Patheon and India’s Kemwell have formed an alliance under which they will refer and market each others' services to development and manufacturing clients
Researchers have used plants from the tobacco family as a large-scale, cost-effective method of producing a HIV inhibitor, which could lead to the creation of a female controlled intervention to stop viral transmission.
Sanofi-Aventis had a €5bn ($6.6bn) bid for Solvay’s pharma business rejected, according to media reports, but several other companies are believed to be interested in the Belgian firm.
Calls for a comprehensive reform of the system of Institutional Review Boards to protect patients in clinical trials have been voiced at a hearing of the House Subcommittee on Oversight and Investigations in the US.
Top 10 contract research organization (CRO) PharmaNet has gone into private hands following the conclusion of its acquisition by private equity firm JLL Partners.
Researchers have created nanoparticles to increase the solubility of probucol, a nearly insoluble drug used to reduce cholesterol, with a technique that could be used for other drugs.
ESS Technologies’ says its unique robotic loading system improves the speed, efficiency and accuracy of pharmaceutical manufacturers’ tube filling and closing operations.
US generic drugmaker Caraco Pharmaceutical Laboratories has recalled batches of its heart drug digoxin after tests revealed the tablets may vary in size and dosage.
Bayer Technology Services GmbH, an affiliate of Germany's Bayer, has opened its first regional office in India, enlarging its presence in the fast-growing Asian markets.
India’s Shasun Chemicals officially closed its pharmaceutical manufacturing plant near Annan in Scotland today yesterday, a little under six months after saying that it was ‘underused’ and could not be kept on as a going concern
Chinese contract research provider WuXi PharmaTech slipped to a fourth quarter loss in 2008, despite reporting a strapping 74 per cent increase in sales.
PTI’s non-destructive micro leak tester can cut costs for companies using dye ingress, according to general manager Heinz Wolf, who demonstrated the technology to in-PharmaTechnologist at Interphex.
Canada’s Winpak has gained an exclusive license to use Reynolds Packaging’s manufacturing know-how in the production of packaging for the drug and healthcare industries.
Flugen has secured the exclusive rights to Ratio’s novel vaccine delivery technology, which is a disposable micro-device that it claims can improve efficacy and compliance.
Custom micronisation and milling firm SDTech has bolted on particle size analysis to its suite of drug industry offerings through a new collaboration with UK analysis specialist Malvern Instruments.
Eli Lilly’s pursuit of outsourcing deals continues unabated with the pharma major entering into a cardiovascular R&D collaboration with Zydus Cadila that has been described as a “new paradigm for global alliances”.
ReceptoPharm, a subsidiary of US biotechnology company Nutra Pharma, is to start offering contract research and manufacturing services for life science companies.
Porsolt, a French contract research organisation (CRO) specialising in preclinical pharmacology services, has said it plans to open a new facility in Europe as well as boost its presence on the other side of the Atlantic.
Pall’s Stax single-use depth filter attracted interest from a “number of biotechnology companies” at Interphex, according to director of marketing Ian Sellick who explained how the system can save space, time and money.
Since coming into effect late last year, US Code of Federal Regulations-21 parts 210 and 211 testing rules have been the subject of much confusion in the pharmaceutical industry, according to West Pharmaceutical Services.
Researchers believe they have found “more promising” sources of shikimic acid, a precursor in the production of Tamiflu, shortages of which have previously caused bottlenecks in producing the bird flu vaccine.
Operations at SAFC Biosciences’ facility in Kansas, US have been made animal component-free (ACF) under a division-wide strategy to keep pace with customer demands and changing regulations.
A US pharmacy’s attempt to implement simpler packaging that clearly communicates information to patients has failed to improve compliance, according to a study.
The committee set up by Patheon to review the unsolicited bid by private equity firm JLL to take control of the firm has asked for advice on the legality of the move.
Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.
Novartis is looking to buy an additional 39 per cent of its majority-owned subsidiary Novartis India for around 4.4bn rupees ($87m), or 351 rupees per share.
Contract manufacturing and packaging firm J-PAC’s addition of thin film converting and sealing capacity to its roster of services completes its offering according to CEO Richard Eagling.
The International Pharmaceutical Excipient Council (IPEC) has unveiled plans to set up a worldwide Federation later this year to address the increasingly global excipient supply chain.
Borealis is launching a new cast film that it claims offers best-in-class transparency, high purity and can be tailored to a client’s needs, making it ideal for packaging manufacturers needing clear coverings.
Senator Grassley has raised concerns that an email by acting Commissioner Torti to FDA employees could be viewed as an attempt to suppress whistleblowers following recent releases of internal agency documents.
Contract drug development group Systems Biology Worldwide (SBW) says the acquisition of Finnish data management specialist 4Pharma will facilitate its entry into the clinical trials sector.
The Chinese unit of US contract drug discovery firm BioDuro says that AstraZeneca has expand its relationship with the firm to include the optimization of discovery research operations focused on drugs for respiratory and inflammatory disease.
US drug delivery specialist Hospira will reduce its workforce by around 10 per cent, or 1,400 employees, over the next 24 months as part of its $140m (€104m) a year “Project Fuel” cost cutting and efficiency drive.
The pharmaceutical rumour mill is still spinning with the latest speculation that UK drug major GSK is interested in Botox manufacturer Allergan causing the US firm’s share price to leap 13 per cent on the New York Stock Exchange.
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.
Hewlett-Packard has made its high-volume digital press commercially available, which it claims can cut waste, warehousing and environmental impact compared to analogue printing.
Regulators in the UK and Australia have issued GMP certificates for Ranbaxy Laboratories' Paonta Sahib plant after a joint inspection deemed manufacturing practices were up to code.
Watson Pharmaceuticals has voluntarily withdrawn one lot of its arrhythmia drug propafenone HCl in the US after the tablets were found to contain slightly higher levels of the drug’s API.
US RNA interference (RNAi) specialist MDRNA has signed a non-exclusive licensing deal granting Swiss drug giant Novartis access to its liposomal siRNA delivery technology platform.
Vetter Pharma-Fertigung (VPF), a specialist provider of pre-filled injection systems, has formed a new subsidiary, Vetter Pharma International (VPI) to take charge of sales, marketing and customer services.
St Patrick’s Day celebrations weren’t the only thing bringing people together in New York last week as the pharmaceutical manufacturing and outsourcing industries gathered at the Jacob K Javits convention centre for Interphex 2009.
Industrial manufacturing specialist Honeywell has been contracted to manage and control production processes at the newly constructed US operations of UK biotechnology company Shire.
SGS Life Science Services opened a new microbiology testing laboratory in Shanghai, China to offer cGMP compliant API testing services for method development and validation.
Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the...
Catalent is adjusting its packaging operations by closing one facility and simultaneously expanding another, which it believes will improve the service offered to its folding carton customers.
